Cargando…
Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated system
Testing is crucial in controlling COVID-19. The Procleix® SARS-CoV-2 assay, a transcription-mediated amplification nucleic acid test that runs on an automated system, was evaluated using inactivated virus and clinical samples. The sensitivity of the assay was assessed using heat-inactivated SARS-CoV...
Autores principales: | Sauleda, Silvia, Palacios, Lourdes, Brès, Vanessa, Piñana, Maria, Alonso-Hernandez, Lorena, Bes, Marta, Piron, Maria, Entrena, Edurne, Minguez-Micolau, Antonio M., Marimón, Jose Maria, Gurrola, Adrian, Soria, Gloria, Puig, Lluís, Antón, Andrés, Pumarola, Tomás, Linnen, Jeffrey M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464401/ https://www.ncbi.nlm.nih.gov/pubmed/34688036 http://dx.doi.org/10.1016/j.diagmicrobio.2021.115560 |
Ejemplares similares
-
Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017‒2020
por: Bes, Marta, et al.
Publicado: (2022) -
Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India
por: Chaurasia, Rahul, et al.
Publicado: (2016) -
HTLV-1/2 Infection in Blood Donors from a Non-Endemic Area (Catalonia, Spain) between 2008 and 2017: A 10-Year Experience
por: Piron, Maria, et al.
Publicado: (2022) -
Evaluation of the Procleix Ultrio Plus ID NAT assay for detection of HIV 1, HBV and HCV in blood donors
por: Makroo, Raj Nath, et al.
Publicado: (2015) -
Specific Plasma MicroRNA Signatures Underlying the Clinical Outcomes of Hepatitis E Virus Infection
por: Costafreda, Maria I., et al.
Publicado: (2023)